DMTK
Price:
$0.094
Market Cap:
$3.29M
DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive genomics tests to diagnosis skin cancer, inflammatory diseases, and aging-related conditions in the United States. It offers DermTech Melanoma Test (DMT), a gene expression test that enhances early detection of genomic atypia and helps rule out melanoma and the need for a surgical biopsy of atypical pigmented lesions. The company also provides adhesive skin sample collection kits, as well as gene expression assays for the Th1, Th2, IFN-gamma, and Th17 inflammatory pathways. In addition, it is developing UV damage DNA risk assessment products, as well as non-melanoma skin cancer diagnostic and cutaneous T-...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2017-08-10
Stock Exchange
NASDAQ
Ticker
DMTK
According to DermTech, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.04. This represents a change of -94.04% compared to the average of -0.60 of the last 4 quarters.
The mean historical PE Ratio of DermTech, Inc. over the last ten years is -73670.15. The current -0.04 PE Ratio has changed -100.00% with respect to the historical average. Over the past ten years (40 quarters), DMTK's PE Ratio was at its highest in in the September 2018 quarter at 6.39K. The PE Ratio was at its lowest in in the June 2016 quarter at -294694.41.
Average
-73670.15
Median
-2.27
Minimum
-589388.81
Maximum
54.41
Discovering the peaks and valleys of DermTech, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 299.98%
Maximum Annual PE Ratio = 54.41
Minimum Annual Increase = -Infinity%
Minimum Annual PE Ratio = -589388.81
Year | PE Ratio | Change |
---|---|---|
2023 | -0.57 | 21.10% |
2022 | -0.47 | -92.11% |
2021 | -5.93 | -62.62% |
2020 | -15.86 | 299.98% |
2019 | -3.97 | -107.29% |
2018 | 54.41 | -100.01% |
2017 | -589388.81 | -Infinity% |
The current PE Ratio of DermTech, Inc. (DMTK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.32
5-year avg
-5.36
10-year avg
-73670.15
DermTech, Inc.’s PE Ratio is less than TransMedics Group, Inc. (1.54K), greater than CuriosityStream Inc. (-2.30), greater than Fulgent Genetics, Inc. (-3.94), greater than Outset Medical, Inc. (-0.16), greater than ClearPoint Neuro, Inc. (-18.16),
Company | PE Ratio | Market cap |
---|---|---|
1.54K | $4.67B | |
-2.30 | $89.54M | |
-3.94 | $648.65M | |
-0.16 | $25.48M | |
-18.16 | $328.11M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like DermTech, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like DermTech, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is DermTech, Inc.'s PE Ratio?
How is the PE Ratio calculated for DermTech, Inc. (DMTK)?
What is the highest PE Ratio for DermTech, Inc. (DMTK)?
What is the 3-year average PE Ratio for DermTech, Inc. (DMTK)?
What is the 5-year average PE Ratio for DermTech, Inc. (DMTK)?
How does the current PE Ratio for DermTech, Inc. (DMTK) compare to its historical average?